Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 56% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 3 citations in OpenAlex.
Life (Basel, Switzerland) · 2026
Review
4 · The record
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors at 2 institutions in 2 countries.
Denise EulálioDepartamento de Química Fundamental, Instituto de Química, Universidade de São Paulo-USP, São Paulo 05508-000, SP, Brazil.ORCID 0000-0002-1721-2494
Mariana Pires FigueiredoDepartamento de Química Fundamental, Instituto de Química, Universidade de São Paulo-USP, São Paulo 05508-000, SP, Brazil.ORCID 0000-0002-9389-2057
Christine Taviot-GuehoInstitut de Chimie de Clermont-Ferrand, Université Clermont Auvergne, BP 10448, F-63000 Clermont-Ferrand, France.ORCID 0000-0002-9468-2684
Fabrice LerouxInstitut de Chimie de Clermont-Ferrand, Université Clermont Auvergne, BP 10448, F-63000 Clermont-Ferrand, France.ORCID 0000-0002-4671-9630
Cristina Helena Dos Reis SerraDepartamento de Farmácia, Faculdade de Ciências Farmacêuticas, Universidade de São Paulo-USP, São Paulo 05508-000, SP, Brazil.ORCID 0000-0002-4250-6603
Dalva Lúcia Araújo de FariaDepartamento de Química Fundamental, Instituto de Química, Universidade de São Paulo-USP, São Paulo 05508-000, SP, Brazil.ORCID 0000-0003-1889-6522
Vera Regina Leopoldo ConstantinoDepartamento de Química Fundamental, Instituto de Química, Universidade de São Paulo-USP, São Paulo 05508-000, SP, Brazil.ORCID 0000-0001-9276-7329
Universidade de São Paulo · BRCentre National de la Recherche Scientifique · FR
Funding
Coordenação de Aperfeicoamento de Pessoal de Nível Superior 88887.352040/2019-00National Council for Scientific and Technological Development 149404/2018-2National Council for Scientific and Technological Development 314034/2021-8Research Academic Cooperation Agreement PRC-CNRS-FAPESP PRC-Projets de recherché conjoints 1688 and SPRINT-São Paulo Researchers in International Collaboration 2016/50317-9São Paulo Research Foundation 2012/13119-3São Paulo Research Foundation 2016/13862-9São Paulo Research Foundation 2016/21070-5São Paulo Research Foundation INCT-INEO 2014/50869-6
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
acetylcysteinehydrotalcite-like compoundsintercalation compoundsin vitro drug releaselayered double hydroxideslayered materialsvibrational spectroscopy
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Development of Dipeptide · full record | OpenQuestion